Professor Frederic Hollande
Fred is Deputy Head at the Dept of Clinical Pathology and works at the University of Melbourne Centre for Cancer Research, located within the Victorian Comprehensive Cancer Centre (VCCC). He obtained his PhD in 1994 from the University of Montpellier, France, then worked as a post-doctoral research fellow at the Ludwig Institute for Cancer Research and the University of Melbourne (94-96). He was recruited as a CNRS Research Fellow in France in 1996 to study molecular mechanisms that underlie the progression of colon cancer.
Fred has been a senior Research Fellow since 2009 and Headed the Oncology Research Department at the Institute of Functional Genomics of Montpellier in 2011-2012. In parallel with his academic work he co-founded in 2007 a small biotech company developing therapeutic monoclonal antibodies. He was the joint-scientific director of this company and designed its Intellectual Property portfolio. The company was acquired by the French Pharmaceutical company Servier in June 2011.
Fred moved to Melbourne in September 2012 to take up a position as Associate Professor in the Department of Pathology at the University of Melbourne. He joined the Department of Clinical Pathology upon its creation in January 2018.
The Hollande Lab is a group of the University of Melbourne Centre for Cancer Research (UMCCR), bringing together university leaders committed to improving the outcomes and quality of life for people affected by cancer.